Graf Akcie TXMD (TherapeuticsMD Inc). Diskuze k akciím TXMD. Aktuální informace TXMD.

Základní informace o společnosti TherapeuticsMD Inc (Akcie TXMD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 283.37M
Hodnota podniku (EV) 375.98M
Tržby 84.788M
EBITDA -123.51
Zisk -156.73
Růst v tržbách Q/Q 114.94 %
Růst v tržbách Y/Y 35.50 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.13
EV/Sales 4.43
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 3.34
P/FCF N/A
Price/Book -2.29
Účetní hodnota na akcii -0.32
Hotovost na akcii 0.20
FCF vůči ceně -45.72 %
Počet zaměstnanců 400
Tržba na zaměstnance 211.969k
Profit margin -282.90 %
Operating margin -146.29 %
Gross margin 75.37 %
EBIT margin -145.80 %
EBITDA margin -145.67 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -42.11 %
EPS - Očekávaný růst příští rok -16.67 %
Return on assets -77.51 %
Return on equity 209.97 %
ROIC -69.23 %
ROCE -91.62 %
Dluhy/Equity -2.46
Čistý dluh/EBITDA -3.80
Current ratio 2.11
Quick Ratio 2.01
Volatilita 5.21
Beta 1.20
RSI 45.91
Cílová cena analytiků 7
Známka akcie (dle analytiků) 1.67
Insider ownership 8.02 %
Institutional ownership 46.20 %
Počet akcií 423.817M
Procento shortovaných akcií 8.77 %
Short ratio 5.72 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2017
Země United States

Finanční výsledky akcie TXMD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$49.647$16.1$16.778$19.357$20.143$15.026
Cost Of Goods Sold$6.335$2.738$2.637$4.186$4.507$3.672
Gross Profit$43.312$13.362$14.141$15.171$15.636$11.354
Research And Development Expenses$19.792$27.299$33.853$53.944$72.043$43.219
SG&A Expenses$174.113$115.989$57.703$51.348$28.721$22.124
Other Operating Income Or Expenses------
Operating Expenses$200.852$146.32$94.406$109.61$105.333$69.067
Operating Income$-151.205$-130.22$-77.629$-90.254$-85.19$-54.041
Total Non-Operating Income/Expense$-24.94$-2.397$0.703$0.378$0.113$-0.176
Pre-Tax Income$-176.145$-132.617$-76.925$-89.876$-85.077$-54.217
Income Taxes------
Income After Taxes$-176.145$-132.617$-76.925$-89.876$-85.077$-54.217
Other Income------
Income From Continuous Operations$-176.145$-132.617$-76.925$-89.876$-85.077$-54.217
Income From Discontinued Operations------
Net Income$-176.145$-132.617$-76.925$-89.876$-85.077$-54.217
EBITDA$-148.958$-129.656$-77.416$-90.121$-85.128$-53.729
EBIT$-151.205$-130.22$-77.629$-90.254$-85.19$-54.041
Basic Shares Outstanding246225206196173150
Shares Outstanding246225206196173150
Basic EPS$-0.72$-0.59$-0.37$-0.46$-0.49$-0.36
EPS - Earnings Per Share$-0.72$-0.59$-0.37$-0.46$-0.49$-0.36
# 2020 2019 2018 2017 2016 2015
Current Ratio3.9324.546910.47619.30486.62695.2604
Long-term Debt / Capital0.95490.4294----
Debt/Equity Ratio21.15340.7524----
Gross Margin87.240782.995484.283178.375677.626575.564
Operating Margin-304.5611-808.848-462.6895-466.2715-422.9291-359.6451
EBIT Margin-304.5611-808.848-462.6895-466.2715-422.9291-359.6451
EBITDA Margin-300.0335-805.3464-461.4192-465.5872-422.6194-357.5654
Pre-Tax Profit Margin-354.7953-823.7367-458.4974-464.3179-422.3673-360.8174
Net Profit Margin-354.7953-823.7367-458.4974-464.3179-422.3673-360.8174
Asset Turnover0.18670.07590.11710.13590.27320.2543
Inventory Turnover Ratio0.53410.83781.77533.88896.533.1061
Receiveable Turnover2.0351.45513.87584.30086.60486.9753
Days Sales In Receivables179.357250.834294.173384.868655.262552.3278
ROE - Return On Equity-1914.388-135.984-59.215-70.4964-134.9077-112.0442
Return On Tangible Equity499.2998-180.6-60.6624-71.8524-138.4539-114.9631
ROA - Return On Assets-66.2235-62.56-53.7076-63.0829-115.3918-91.7699
ROI - Return On Investment-86.4152-77.5969-59.2149-70.4964-134.9077-112.0442
Book Value Per Share0.03390.40560.60020.64820.35440.31
Operating Cash Flow Per Share-0.1979-0.1042-0.01790.1038-0.1524-0.1412
Free Cash Flow Per Share-0.2069-0.1048-0.01620.1028-0.1532-0.1411